118 related articles for article (PubMed ID: 32131602)
1. Rizikové faktory a surveillance hepatocelulárního karcinomu.
Fraňková S; Šperl J
Vnitr Lek; 2019; 65(9):583-587. PubMed ID: 32131602
[TBL] [Abstract][Full Text] [Related]
2. Congenital anomalies in children born in the Czech Republic in 1994-2015.
Šípek A; Gregor V; Šípek A; Klaschka J; Malý M; Jírová J
Cas Lek Cesk; 2019; 158(1):9-14. PubMed ID: 31046386
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of endometriosis 1st part - Overview of diagnostic approaches.
Indrielle-Kelly T; Frühauf F; Burgetová A; Fanta M; Fischerová D
Ceska Gynekol; 2019; 84(4):252-259. PubMed ID: 31818107
[TBL] [Abstract][Full Text] [Related]
4. Hashimotos thyroiditis.
Hamous J; Dvořák J; Bušovský I; Šnajdr M
Rozhl Chir; 2021; 100(3):110-112. PubMed ID: 33910355
[TBL] [Abstract][Full Text] [Related]
5. Analysis of fatal industrial accidents in forensic postmortem investigations in South Osaka.
Naoto T; Tomoya I; Shigeki O; Fumiya M; Kei I; Alissa S; Yayoi A; Takaki I
Soud Lek; 2020; 65(3):56-60. PubMed ID: 33076672
[TBL] [Abstract][Full Text] [Related]
6. Neuromonitoring of recurrent laryngeal nerves in thyroid surgery comparative study of visualisation and electrophysiology methods.
Astl J; Holý R; Rotnágl J; Hložek J
Rozhl Chir; 2021; 100(3):113-117. PubMed ID: 33910356
[TBL] [Abstract][Full Text] [Related]
7. P21-Associated ncRNA DNA Damage-Activated Expression in Bladder Cancer.
Abdolmaleki F; Ghafouri-Fard S; Taheri M; Omrani DM
Klin Onkol; 2019; 32(4):277-280. PubMed ID: 31426643
[TBL] [Abstract][Full Text] [Related]
8. Functional gastrointestinal disorders and pain.
Lukáš K
Vnitr Lek; 2019; 65(11):674-677. PubMed ID: 31906672
[TBL] [Abstract][Full Text] [Related]
9. Can gram-negative-like biomarker values in Streptococcus pyogenes sepsis negatively influence right choice of initial antibiotic therapy?
Adámková V; Lahoda Brodská H; Adámková V; Zima T
Epidemiol Mikrobiol Imunol; 2020; 69(3):128-133. PubMed ID: 33086854
[TBL] [Abstract][Full Text] [Related]
10. Rates of cirrhosis and hepatocellular carcinoma in chronic hepatitis B and the role of surveillance: a 10-year follow-up of 673 patients.
Poh Z; Goh BB; Chang PE; Tan CK
Eur J Gastroenterol Hepatol; 2015 Jun; 27(6):638-43. PubMed ID: 25831135
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS
Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
[TBL] [Abstract][Full Text] [Related]
13. Crime scene investigation and dynamic reconstruction: importance of synergic collaboration between forensic pathology and digital reconstruction for work-related fatalities.
Alessandro F; Giulio MD; Francesco S; Carmela G; Bruno PD
Soud Lek; 2021; 66(1):2-5. PubMed ID: 34275301
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis.
Worland T; Harrison B; Delmenico L; Dowling D
J Gastrointest Cancer; 2018 Dec; 49(4):476-480. PubMed ID: 28920172
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: analysis of the factors influencing AFP elevation without HCC development].
Kim KA; Lee JS; Jung ES; Kim JY; Bae WK; Kim NH; Moon YS
Korean J Gastroenterol; 2006 Nov; 48(5):321-6. PubMed ID: 17132920
[TBL] [Abstract][Full Text] [Related]
16. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of hepatocellular carcinoma surveillance in patients with hepatitis C virus-related cirrhosis.
Patel D; Terrault NA; Yao FY; Bass NM; Ladabaum U
Clin Gastroenterol Hepatol; 2005 Jan; 3(1):75-84. PubMed ID: 15645408
[TBL] [Abstract][Full Text] [Related]
18. Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
Tavakoli H; Robinson A; Liu B; Bhuket T; Younossi Z; Saab S; Ahmed A; Wong RJ
Dig Dis Sci; 2017 Aug; 62(8):2174-2181. PubMed ID: 28474143
[TBL] [Abstract][Full Text] [Related]
19. Low Rates of Retention Into Hepatocellular Carcinoma (HCC) Surveillance Program After Initial HCC Screening.
Robinson A; Tavakoli H; Cheung R; Liu B; Bhuket T; Wong RJ
J Clin Gastroenterol; 2019 Jan; 53(1):65-70. PubMed ID: 29629906
[TBL] [Abstract][Full Text] [Related]
20. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
